Emerging mechanisms controlling immunoinflammatory response during atherogenesis

30 August 2026 (17:54 - 18:06)

Organised by:

About the speaker

Miss Marie Depuydt

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail

Remnant cholesterol and triglyceride-rich lipoproteins: what human genetics tells us about causality beyond LDL

Professor A. Tybjaerg-Hansen (Copenhagen, DK)

Presentation thumbnail

Lp(a), aortic valve stenosis, and atherosclerosis

Doctor S. Kraler (Zurich, CH)

Presentation thumbnail

Targeting deoxyribonucleic acid and ribonucleic acid in the context of lipid-lowering and vascular disorders

Professor N. Bouatia-Naji (Paris, FR)

Presentation thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein? - discussion

Access the full session

Session thumbnail

New targets for lipid-lowering and atherosclerosis: what's beyond low-density lipoprotein?

The Event

Event poster

ESC Congress 2026

30 August 2026 17:54 CET

You may be interested in

Webinar

Recent advances in immune pathways in atherosclerosis

21 April 2021

Congress Presentation

SET7 lysine methyltransferase mediates NLRP3 inflammasome priming and activation in atherosclerotic apolipoprotein E knockout mice

11 May 2024

Webinar

Quantification of coronary inflammation using coronary CT angiography to improve patient risk prediction and stratification

27 September 2021

Congress Presentation

NEU1 increases monocyte and macrophage-mediated inflammation and may act as a potential modulator of atherosclerosis

21 April 2018

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources